The Forensic Factor (TFF) believes that individual investors are disadvantaged when investing in certain smaller companies. TFF believes we can profit from market inefficiencies while also identifying companies that are misrepresenting their prospects or financial results. By illuminating corruption in the capital markets, individual investors can make more informed decisions when investing hard-earned capital....
With that said, TFF is a profit organization and will frequently trade in the securities about which we write. Our positions will always be disclosed in the posting. TFF goes to great lengths to ensure that all information is factual and referenced. All facts that we present on this site are true to the best of our knowledge. All opinions presented are our own and accurately reflect our actual opinion on the relevant subject being discussed at the time
Adelphi Venture Capital invests in private and listed companies.
Over 30 years in the industry enables insightful equity research that provides alpha for readers.
Just another guy with a day job and an obsession with the stock market... my goal is to achieve FI (financial independence) by investing in growth and turnaround stocks.
Value Catalyst Investor/Value Where I can Find It
I strive to provide actionable ideas that are capable of generating alpha for my readers, while never losing my sense of skepticism in the midst of the chaotic mix of euphoria and pessimism known as Wall Street.
Remember, there are no shortcuts. Do your own research, get your financial house in order, have your own sell rules, and check your ego at the door, as the market eventually humbles us all time and again.
2016 Favorite Winners Identified for Readers (Start Date June 12):
Galapagos (GLPG)- Identified as core biotech holding whose assets were largely undervalued by the market, with upcoming catalysts in cystic fibrosis & IPF, not to mention heavy weight partnerships and being a possible medium term acquisition target
Apigee (APIC) identified as key IoT play for readers, bought out by Google
Retrophin (RTRX) identified as core biotech holding trading at a depressed valuation due to involvement with prior CEO, where commercial business worth more than present valuation and pipeline offered near term upside potential
Zynerba Pharmaceuticals (ZYNE)- Identified relative value disconnect between early stage marijuana biotech and late stage competitor GWPH, arguing that near term catalysts could shorten gap from 30x to 4-8x
*A final note, I´m very thankful to Seeking Alpha for creating a transparent forum where investors can share their ideas, DD, strategies and high conviction picks. I appreciate every follow and the positive feedback I´ve been getting- it´s why I keep at it. Constructive criticism, bear thesis on my long picks, and other ideas on how to improve articles for readers are always welcome (when done in a civil manner).
Shark Traders is a prop firm providing online access and leverage for trading on NYSE, NASDAQ and AMEX to traders from all over the world. We work with few clearing firms and serve hundreds of traders helping their business grow.
I am just an undergraduate student about to graduate with a B.B.A. in Finance and B.A. in Economics. Obviously I have low professional expertise, but a high desire to learn. I have been investing since the summer of 2012 and my focus is on growth potential, value, and momentum. I make trades relatively infrequently, about every month or so, mainly because I do not have a lot of extra cash lying around (I am in college afterall). But I enjoy doing research and finding opportunities even if I cannot capitalize on them myself. Eventually, I would like to become a financial analyst (I have passed the first level of the CFA exam).
Hi everyone, my name is Khen Elazar and I am a 25 years old student for political science. I currently work in an insurance agency in Israel, and studying to become a financial adviser. Hopefully, I will find the time to study for a master's degree in the near future. I am investing in the stock market since I was 17 years old. I did it with the help and guidance of my father who is an investment adviser. I used to invest in value and growth stocks, and in Israeli junk bonds. Over the past two years, I have been investing mainly in dividend growth stocks. I also enjoy reading and study new things. I am a political junkie and sport enthusiast, mainly soccer and NBA.
I am a private investor based out of Toronto, Canada and I have been investing since 2003. After 8 years in Corporate Finance with a Canadian Telecom company I have decided to dedicate myself full-time to the capital markets. I write on Seeking Alpha to demonstrate my financial analysis and writing skills across a variety of industries and to take advantage of any story-based trading opportunity that may arise. My passion and greatest depth of knowledge is on Canadian small cap stocks and I consider my blog posts to be some of my best work. I am interested in any freelance opportunities that may arise outside of Seeking Alpha on Canadian or American listed stocks.
I'm currently an analyst at BMO Nesbitt Burns in Vancouver at Hamilton & Associates. I have my CFA Level 2 (and am pursuing Level 3), and I have an intense passion for the markets, and write some thoughts on stocks, or other themes, from time to time.
Formerly of the buy side now an aspiring beet and raspberry farmer. Soon to be expired CFA Charterholder. I like long walks through the aisles of Aldi, dark roast coffee from Tim Horton's, and climbing mountains on two wheels.
The posts are meant to be informative and hopefully insightful. I write to share my ideas, highlight some interesting stories and to interact with other investors - please feel free to contact me if you'd like to chat further.
I make lot's of mistakes so please do your own due diligence. I don't intend to aggressively promote stocks but it's fair to say I am often talking my own book.
I seek out companies that have the ability to generate above-average growth for many years, before ultimately becoming a shareholder-friendly, dividend paying titan, cementing its spot in my portfolio with an incredibly low cost basis due to the previous years of steady, strong growth. These are Future Blue Chips!
I really enjoy helping people with trying to understand the market. Seeking Alpha is for connecting with other investors and it has a lot of people that are willing to lend a helping hand. If you have ANY questions with options or the general market, feel free to ask! :)
www.FutureBlueChips.com -- Try my Newsletter, it's completely free!
I am a young investor who is doing more with my money in investments than those of my generation.
Education and Investment Background
I have a Bachelors of Science in Computer & Electrical Engineering. I follow technology related companies as well as blue chip industrials and consumer products. I enjoy writing about technology companies, especially ones that I use and consume. Knowing the technical side of the products helps in my analysis of what the product impact is to consumers and the markets they reach. I'm interested in growth stocks but still have a portfolio of dividend growth companies to balance out risk.
I work for a technology contracting company doing configuration management. This entails automating workflows and delivery of developed code using change control and version control software. The sector of my work is governmental and deals with the department of health.
I previously worked in the IT field of the healthcare industry for a major teaching hospital and practice group. I worked mostly with integration engines for use with hundreds of systems as well as end user application access and security including single sign-on.
A Little About Me...
I enjoy a variety of hobbies including playing drums and building race cars made for the ice and asphalt. I raced nationally in college for Baja SAE and continue to build cars and race on a regional level both on road courses and frozen lakes.
Searching the market for high-quality assets at a discounted price. Investment horizon is always medium- to long-term (12 months or more), and will often act as a contrarian to short-term consensus in order to identify the best investment opportunities. Tend to focus on energy and technology sectors.
Individual investor focused upon a limited number of diversified stocks. Seeks stocks selling below fair value; favors dividend growth. Advocates fundamental investment analysis, supplemented by the technical charts. Options strategies primarily employed to generate additional income or hedge risk.
Dr Jonathan Kinlay is the Head of Quantitative Trading at Systematic Strategies, LLC, a systematic hedge fund that deploys high frequency trading strategies using news-based algorithms.
Dr Kinlay, was the founder and General Partner of the Caissa Capital hedge fund, whose volatility arbitrage strategies were developed by Dr Kinlay’s investment research firm, Investment Analytics. Caissa, which managed $400M in assets, was ranked by FIMAT as the top performing fund in its class in 2004. Dr Kinlay went on to establish the Proteom Capital, whose statistical arbitrage strategies were based on pattern recognition techniques used in DNA sequencing. Dr Kinlay was formerly Global Head of Model Review at the US investment bank Bear Stearns.
Dr Kinlay holds a PhD in economics and has held positions on the faculty at New York University Stern School of Business, Carnegie Mellon and Reading Universities. Dr Kinlay is a regular conference speaker and writer on investment research, hedge fund investing and quantitative finance. Kinlay was a member of England’s chess team that won gold in the World Student Olympiad in Mexico in 1978. He is the son of Fleet Street editor James Kinlay and father of British actress Antonia Kinlay.
Further investment research and strategy ideas can be found in his blog at www.jonathankinlay.com .
MSc Inventment Managment 2005
Cass Business School
City University of London
I started trading when I was 20 years old by shorting orange juice futures! And yes the results were not pretty....
Here is my public performance at Marketocracy which the long fund started November of 2000:
Here is my Short fund which started in October of 2007 and is now mostly in cash:
Bob O’Donnell is the founder and chief analyst of TECHnalysis Research, LLC a technology consulting and market research firm that provides strategic consulting and market research services to the technology industry and professional financial community. You can follow him on Twitter @bobodtech.
Black Coral Research, Inc. is a newsletter designed to inform Dividend Investors how the latest news could impact the dividends of the companies they invest in. Feel free to contact us at BlackCoralResearch@gmail.com
Full-time investor with a medium-term outlook. Former equity research intern and a senior year undergraduate student.
In order to track the news and data I am focusing on, as well as to be aware of my positions, please consider following me on twitter: @AntonTyumin
Thank you for reading my articles. I am always open to any investment-related conversations, so feel free to contact me either here or by email: email@example.com
Lipper Alpha Insight (http://lipperalpha.financial.thomsonreuters.com/) is a free daily news and commentary blog, giving financial professionals actionable ideas and insight to make sense of individual security news and events and stay on top of macroeconomic trends. We have a team of expert analysts that are constantly looking at the financial landscape in order to keep you up to date on the latest movements.
I am mostly a daytrader engaging in both long and short bets intraday and occasionally over the short to medium term. My focus is mostly on tech stocks and more recently the shipping and offshore drilling industry.
I am located in Germany and have worked many years as an auditor for PricewaterhouseCoopers before becoming a daytrader almost 15 years ago.
During this time I managed to successfully maneuver the burst of the dotcom bubble and the aftermath of the world trade center attacks as well as the subprime crisis.
My return on employed capital has been mostly good and at times reaches up to several 100% annually so I guess I will be around for some more years.
Covering especially stocks in Germany & Europe with a combination of deep value and event-driven/distressed character.
Conversant with and by the followed former industries/emplyoers:
- MLP AG: Financial Services / Advisory
- Deutsche Boerse AG: Product and Sales Management of Derivatives
- Nord/LB Asset Management Holding: Master Desk and Investment Controlling
- BNP Paribas: Corporate and Investment Banking
- Aramea Asset Management AG (Currently): Portfolio- and Risk Management
- GreenRiver Capital (Currently): Founder and Holder - capital market analysis with future target to issue an alternative investment fund.
- Double Bachelor Degree from University of Applied Science Bremen, Germany and Kedge Business School Marseille, France with a main Focus on finance
- Master Degree in "Management and Financial Institutions" from Leuphana University, Germany
I have had 4 years of experience in investing, several internships in corporate finance in advisory and in industrial companies. I am currently working in investment banking where my role includes origination and execution of mergers and acquisition deals. I also have done research on several stocks, mostly in biotech and technology. I believe I will be a great asset for the investors' community at Seeking Alpha. My strategy mostly includes mid-term value investing with exposure to pharmaceuticals, biotech and technology sectors.
-Professional asset management.
Solutions for private investors.
Interactive Brokers Java API
I do things like what this algo trader does:
Java Swing App. algo: https://www.youtube.com/watch?v=wU4odLFcDrE
Market orders: https://www.youtube.com/watch?v=ZvOkWsSkFbg
Folow me on:
twitter: @Maudes_Capital / linkedin: Maudes Capital
/ Facebook: https://www.facebook.com/profile.php?id=100013485136058